🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to determine the safety, tolerability, pharmacokin...
Status
Completed
Location
The University of Texas MD Anderson Cancer Center
Start Date
2010-10
Trial ID
NCT01221571
Treatments Being Tested
The study is designed * to demonstrate efficacy of AFM13 with an optimized...
Status
Completed
Location
1st Department of Medicine, Cologne University Hospital
Start Date
2015-05
Trial ID
NCT02321592
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of modified um...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2020-07-18
Trial ID
NCT04074746
This is a phase II study to evaluate the antitumor activity and safety of A...
Status
Completed
Location
University of Alabama at Birmingham (O'Neal Comprehensive Cancer Center)
Start Date
2019-11-13
Trial ID
NCT04101331
Treatments Being Tested
The investigators plan to investigate AFM13 and evaluate its ability to fac...
Status
Completed
Location
Center for Lymphoid Malignancies
Start Date
2017-07-17
Trial ID
NCT03192202
Treatments Being Tested
The purpose of this study is to establish a dosing regimen for the combinat...
Status
Completed
Location
University of Alabama Comprehensive Cancer Center
Start Date
2016-05
Trial ID
NCT02665650
Treatments Being Tested
AFM13-203 is a phase 2, open-label, multi-center, multi-cohort study with a...
Status
Terminated
Location
O'Neal Comprehensive Cancer Center at UAB
Start Date
2023-10-10
Trial ID
NCT05883449
Treatments Being Tested